These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9827698)

  • 1. Early effects of pp60(v-src) kinase activation on caveolae.
    Ko YG; Liu P; Pathak RK; Craig LC; Anderson RG
    J Cell Biochem; 1998 Dec; 71(4):524-35. PubMed ID: 9827698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveolin-1 and a 29-kDa caveolin-associated protein are phosphorylated on tyrosine in cells expressing a temperature-sensitive v-Abl kinase.
    Corley Mastick C; Sanguinetti AR; Knesek JH; Mastick GS; Newcomb LF
    Exp Cell Res; 2001 May; 266(1):142-54. PubMed ID: 11339833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-tyrosine kinase activity and pp60v-src expression in whole cells measured by flow cytometry.
    Preis PN; Waldman FM; Frackelton AR; Saya H; Levin VA
    Cancer Res; 1988 Aug; 48(16):4633-8. PubMed ID: 3135116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clustered cysteine residues in the kinase domain of v-Src: critical role for protein stability, cell transformation and sensitivity to herbimycin A.
    Senga T; Miyazaki K; Machida K; Iwata H; Matsuda S; Nakashima I; Hamaguchi M
    Oncogene; 2000 Jan; 19(2):273-9. PubMed ID: 10645006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of orthovanadate on commitment of avian myoblasts transformed with Rous sarcoma virus to myogenic differentiation.
    Hase H; Isobe A; Kim J
    Eur J Cell Biol; 1995 Nov; 68(3):313-22. PubMed ID: 8603684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herbimycin A inhibits the association of p60v-src with the cytoskeletal structure and with phosphatidylinositol 3' kinase.
    Hamaguchi M; Xiao H; Uehara Y; Ohnishi Y; Nagai Y
    Oncogene; 1993 Mar; 8(3):559-64. PubMed ID: 8382356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the viral and cellular Src kinases to perinuclear vesicles in fibroblasts.
    Redmond T; Brott BK; Jove R; Welsh MJ
    Cell Growth Differ; 1992 Sep; 3(9):567-76. PubMed ID: 1384654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential subcellular membrane recruitment of Src may specify its downstream signalling.
    de Diesbach P; Medts T; Carpentier S; D'Auria L; Van Der Smissen P; Platek A; Mettlen M; Caplanusi A; van den Hove MF; Tyteca D; Courtoy PJ
    Exp Cell Res; 2008 Apr; 314(7):1465-79. PubMed ID: 18316074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM; Eby JC; Disatnik MH; Rando TA
    J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo.
    Li S; Seitz R; Lisanti MP
    J Biol Chem; 1996 Feb; 271(7):3863-8. PubMed ID: 8632005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogenic phospholipase D activity is restricted to caveolin-enriched membrane microdomains.
    Xu L; Shen Y; Joseph T; Bryant A; Luo JQ; Frankel P; Rotunda T; Foster DA
    Biochem Biophys Res Commun; 2000 Jun; 273(1):77-83. PubMed ID: 10873567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
    Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
    J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen-mediated tyrosine phosphorylation of caveolin-1 and its effect on the oestrogen receptor localisation: an in vivo study.
    Kiss AL; Turi A; Müllner N; Kovács E; Botos E; Greger A
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):128-37. PubMed ID: 16368181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphorylation of NOS3 in a breast cancer cell line and Src-transformed cells.
    Takenouchi Y; Oo ML; Senga T; Watanabe Y; Machida K; Miyazaki K; Nimura Y; Hamaguchi M
    Oncol Rep; 2004 May; 11(5):1059-62. PubMed ID: 15069547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive diffuse activation of phosphoinositide 3-kinase at the plasma membrane by v-Src suppresses the chemotactic response to PDGF by abrogating the polarity of PDGF receptor signalling.
    Platek A; Vassilev VS; de Diesbach P; Tyteca D; Mettlen M; Courtoy PJ
    Exp Cell Res; 2007 Apr; 313(6):1090-105. PubMed ID: 17335807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin scaffolding region and the membrane binding region of SRC form lateral membrane domains.
    Wanaski SP; Ng BK; Glaser M
    Biochemistry; 2003 Jan; 42(1):42-56. PubMed ID: 12515538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary analysis and molecular dissection of caveola biogenesis.
    Kirkham M; Nixon SJ; Howes MT; Abi-Rached L; Wakeham DE; Hanzal-Bayer M; Ferguson C; Hill MM; Fernandez-Rojo M; Brown DA; Hancock JF; Brodsky FM; Parton RG
    J Cell Sci; 2008 Jun; 121(Pt 12):2075-86. PubMed ID: 18505796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Src as a novel atypical protein kinase C-interacting protein.
    Seibenhener ML; Roehm J; White WO; Neidigh KB; Vandenplas ML; Wooten MW
    Mol Cell Biol Res Commun; 1999 Jul; 2(1):28-31. PubMed ID: 10527887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of agents which convert 'transformed morphology' of Rous sarcoma virus-infected rat kidney cells to 'normal morphology': identification of an active agent as herbimycin and its inhibition of intracellular src kinase.
    Uehara Y; Hori M; Takeuchi T; Umezawa H
    Jpn J Cancer Res; 1985 Aug; 76(8):672-5. PubMed ID: 3930444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27).
    Wang XB; Lee H; Capozza F; Marmon S; Sotgia F; Brooks JW; Campos-Gonzalez R; Lisanti MP
    Biochemistry; 2004 Nov; 43(43):13694-706. PubMed ID: 15504032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.